You are here

Our science / Clinical Trials / Find a Trial / NCT00003673

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Back to Search Print Save as PDF Bookmark Trial

NCT00003673

Last updated on February 21, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Arizona Cancer Center
Tucson, Arizona, 85724 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Leukemia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
60 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details
Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
NCT00003673
Pfizer
Completed
CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Acute Myeloid Leukemia
Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
NCT00161668
All Genders
18+
Years
Multiple Sites
Acute Myeloid Leukemia
A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia
NCT02954653
All Genders
18+
Years
Multiple Sites
Leukemia
CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse
NCT00003131
All Genders
18+
Years
Multiple Sites
CD33 Positive Acute Myelogenous Leukemia
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
NCT02312037
All Genders
0+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now